Injective Coin has been experiencing significant traction recently, especially with the launch of its EVM Testnet and the RWA Tokenization, expected to skyrocket the INJ price beyond $12. Further fuelling excitement is the recent news about Telekom becoming a top 10 validator on the Injective Network, contributing to the growing consensus that the INJ could reach a new all-time high this year. The on-chain usage for INJ has surged 46.78% while the price has also significantly risen with the start of the INJ 3.0 era. Moreover, Injective has launched a Testnet with a Unified VM layer which has further boosted the INJ token value. Amid geopolitical ceasefire hopes, INJ gained a whopping 26%. With the reveal of AI platform iBuild, new revenue fund, and council at the New York Summit, Injective promises future growth. A recent merge with Deutsche Telekom subsidiary makes Injective's blockchain more credible, and the INJ protocol enters a mega breakout by pumping 12% to $25. Injective's 3.0 upgrade sparks INJ rally amidst deflationary promise and brings native EVM support, unlocking Ethereum dApps on its blockchain. In 2025, the price of INJ is predicted to potentially reclaim $50 which aligns with the increasing on-chain activity and bullish momentum of the altcoin market that Injective is part of. Despite some hurdles, including trade war and AI chaos, INJ has the potential to recover due to its innovations in Web3 and native AI agent hub supporting its protocols. However, investors are advised to remain cautious and conduct their research before investing as the outcomes are predictions and not guaranteed.
Injective Coin News Analytics from Wed, 23 Dec 2020 08:00:00 GMT to Wed, 09 Jul 2025 11:24:12 GMT -
Rating 7
- Innovation 7
- Information 8
- Rumor 6